Oral psoralen-UV-A for systemic scleroderma.
Explore the source record for details and available documents.
Administration, Oral↗
SEARCH · PubMed Health
Results for “Scleroderma, Systemic”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Systemic scleroderma in mother and daughter.
Explore the source record for details and available documents.
Adult↗
Progressive systemic scleroderma with iga deficiency in a child.
Explore the source record for details and available documents.
Child↗
Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma.
Explore the source record for details and available documents.
Adult↗
Progressive systemic scleroderma in an infant with partial phenylketonuria.
Explore the source record for details and available documents.
Adrenal Cortex Hormones↗
Bilateral acquired Brown syndrome in systemic scleroderma.
Explore the source record for details and available documents.
Diplopia↗
[Lung disease in systemic scleroderma].
Explore the source record for details and available documents.
Humans↗
[Treatment of systemic scleroderma: update].
Explore the source record for details and available documents.
Acute Kidney Injury↗
[Lymphocytic lymphoma and regenerative liver nodular hyperplasia in systemic scleroderma].
Explore the source record for details and available documents.
Causality↗
[D-penicillamine: an outdated cure for systemic scleroderma?].
Explore the source record for details and available documents.
Antirheumatic Agents↗
[Myasthenia associated with systemic scleroderma].
Explore the source record for details and available documents.
Aged↗
[Plexopathy associated with systemic scleroderma].
Explore the source record for details and available documents.
Brachial Plexus Neuropathies↗
[Long-term results of the treatment of diffuse systemic scleroderma with interferon-gamma].
There are very few drugs effective in the treatment of diffuse scleroderma and therefore we conducted an open study with gamma interferon. Among 20 diffuse scleroderma, evolving since less than 3 years, an improvement was observed in 8 patients. There was no serious side effect. Survival of these 20 patients was 85% at 5 years.
Adult↗
[Systemic scleroderma and cancer].
Explore the source record for details and available documents.
Humans↗
[Systemic scleroderma and sarcoma of the mesentery].
Explore the source record for details and available documents.
Female↗
[Environmental factors and iatrogenic elements in systemic scleroderma and related syndromes. Review of the literature].
The etiology of scleroderma remains unknown. Although a genetic susceptibility seems to play a role, some environmental and iatrogenic factors have been suggested to trigger the disease. Contact for many months or years with natural or synthetic "toxic" products (by inhalation, cutaneous contact, injection, swallowing or surgical implant) could be implicated in the development of typical scleroderma or pseudo-scleroderma. These products are either occupational or non occupational like those used at home in daily life. We will sum up the knowledges about this subject.
Environmental Exposure↗